These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 2611825

  • 21. Effects of slow-release bezafibrate on serum lipids, lipoproteins, apolipoproteins, and postheparin lipolytic activities in patients with type IV and type V hypertriglyceridemia.
    Saku K, Sasaki J, Arakawa K.
    Clin Ther; 1989; 11(3):331-40. PubMed ID: 2743372
    [Abstract] [Full Text] [Related]

  • 22. Effects of lovastatin (20-80 mg daily) on lipoprotein fractions in patients with severe primary hypercholesterolemia.
    März W, Grützmacher P, Paul D, Siekmeier R, Schoeppe W, Gross W.
    Int J Clin Pharmacol Ther; 1994 Feb; 32(2):92-7. PubMed ID: 8004365
    [Abstract] [Full Text] [Related]

  • 23. [Effect of combined treatment with lovastatin and colestipol on serum lipids and lipoproteins].
    Kłosiewicz-Latoszek L, Nowicka G, Szostak WB.
    Wiad Lek; 1993 Aug; 46(15-16):581-5. PubMed ID: 7975581
    [Abstract] [Full Text] [Related]

  • 24. [Lowering of the plasma lipid concentration with lovastatin. A clinical study in patients with primary hypercholesterolemia].
    Grüneberger S, Dreyer M, Kangah R, Reinicke A, Staisch C, Steinhagen-Thiessen E, Müller P, Simon B, Dammann HG.
    Dtsch Med Wochenschr; 1989 Nov 10; 114(45):1734-9. PubMed ID: 2806106
    [Abstract] [Full Text] [Related]

  • 25. Tolerability and effects on lipids of ezetimibe coadministered with pravastatin or simvastatin for twelve months: results from two open-label extension studies in hypercholesterolemic patients.
    Strony J, Hoffman R, Hanson M, Veltri E.
    Clin Ther; 2008 Dec 10; 30(12):2280-97. PubMed ID: 19167588
    [Abstract] [Full Text] [Related]

  • 26. Cholesterol-lowering therapy after heart transplantation: a 12-month randomized trial.
    Pflugfelder PW, Huff M, Oskalns R, Rudas L, Kostuk WJ.
    J Heart Lung Transplant; 1995 Dec 10; 14(4):613-22. PubMed ID: 7578166
    [Abstract] [Full Text] [Related]

  • 27. Efficacy of once-daily extended-release lovastatin as compared to immediate-release lovastatin in patients with hypercholesterolemia.
    Lukacsko P, Walters EJ, Cullen EI, Niecestro R, Friedhoff LT.
    Curr Med Res Opin; 2004 Jan 10; 20(1):13-8. PubMed ID: 14741066
    [Abstract] [Full Text] [Related]

  • 28. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
    Kanbay M, Delibasi T, Kaya A, Aydogan T, Koca C, Akcay A, Duranay M, Yigitoglu R.
    Ren Fail; 2006 Jan 10; 28(7):567-71. PubMed ID: 17050239
    [Abstract] [Full Text] [Related]

  • 29. Efficacy of low-dose cholesterol-lowering drug therapy in men with moderate hypercholesterolemia.
    Denke MA, Grundy SM.
    Arch Intern Med; 1995 Feb 27; 155(4):393-9. PubMed ID: 7848022
    [Abstract] [Full Text] [Related]

  • 30. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
    Strandberg TE, Feely J, Sigurdsson EL, DISCOVERY study group.
    Clin Ther; 2004 Nov 27; 26(11):1821-33. PubMed ID: 15639694
    [Abstract] [Full Text] [Related]

  • 31. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.
    Alvarez-Sala LA, Cachofeiro V, Masana L, Suarez C, Pinilla B, Plana N, Trias F, Moreno MA, Gambus G, Lahera V, Pintó X.
    Clin Ther; 2008 Jan 27; 30(1):84-97. PubMed ID: 18343245
    [Abstract] [Full Text] [Related]

  • 32. [Lovastatin: short-term treatment of hypercholesterolemia; multicenter clinical trial].
    Brusco OJ.
    Medicina (B Aires); 1990 Jan 27; 50(1):69-73. PubMed ID: 2292916
    [Abstract] [Full Text] [Related]

  • 33. [Multicenter comparative study on safety, tolerance, and effectiveness of lovastatin combined or not with cholestyramine, and gemfibrozil combined or not with cholestyramine in the treatment of primary hypercholesterolemia].
    Jover E, Aranda JL, Nogués X, del Palacio A, Rubiés-Prat J.
    Med Clin (Barc); 1996 May 25; 106(20):776-9. PubMed ID: 8801396
    [Abstract] [Full Text] [Related]

  • 34. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
    Jones PH, Hunninghake DB, Ferdinand KC, Stein EA, Gold A, Caplan RJ, Blasetto JW, Statin Therapies for Elevated Lipid Levels Compared Across Doses to Rosuvastatin Study Group.
    Clin Ther; 2004 Sep 25; 26(9):1388-99. PubMed ID: 15531001
    [Abstract] [Full Text] [Related]

  • 35. Low plasma lipid levels and increased cholesterol synthesis after partial ileal bypass plus lovastatin in hypercholesterolemic rabbits.
    Tijerina O, Dombrovskis S, Esper E, Matts JP, Campos CT, Buchwald H.
    Surgery; 1988 Oct 25; 104(4):796-805. PubMed ID: 3175875
    [Abstract] [Full Text] [Related]

  • 36. [The effect of lovastatin in the treatment of primary hypercholesterolemia].
    Chi JM, Li LS, Sun MZ.
    Zhonghua Nei Ke Za Zhi; 1992 Jan 25; 31(1):32-4, 61. PubMed ID: 1395911
    [Abstract] [Full Text] [Related]

  • 37. Lifibrol: a novel lipid-lowering drug for the therapy of hypercholesterolemia. Lifibrol Study Group.
    Locker PK, Jungbluth GL, Francom SF, Hughes GS.
    Clin Pharmacol Ther; 1995 Jan 25; 57(1):73-88. PubMed ID: 7828385
    [Abstract] [Full Text] [Related]

  • 38. Safety and efficacy of combined gemfibrozil-lovastatin therapy for primary dyslipoproteinemias.
    Glueck CJ, Speirs J, Tracy T.
    J Lab Clin Med; 1990 May 25; 115(5):603-9. PubMed ID: 2341762
    [Abstract] [Full Text] [Related]

  • 39. Oat-derived beta-glucan significantly improves HDLC and diminishes LDLC and non-HDL cholesterol in overweight individuals with mild hypercholesterolemia.
    Reyna-Villasmil N, Bermúdez-Pirela V, Mengual-Moreno E, Arias N, Cano-Ponce C, Leal-Gonzalez E, Souki A, Inglett GE, Israili ZH, Hernández-Hernández R, Valasco M, Arraiz N.
    Am J Ther; 2007 May 25; 14(2):203-12. PubMed ID: 17414591
    [Abstract] [Full Text] [Related]

  • 40. Effects of policosanol and lovastatin on lipid profile and lipid peroxidation in patients with dyslipidemia associated with type 2 diabetes mellitus.
    Castaño G, Menéndez R, Más R, Amor A, Fernández JL, González RL, Lezcay M, Alvarez E.
    Int J Clin Pharmacol Res; 2002 May 25; 22(3-4):89-99. PubMed ID: 12837046
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.